在玻璃眼中代谢失调
Xirui Yang1, Songwei Li2, Hao Guo1
1Department of Ophthalmology, First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China.
Clinical & experimental optometry
|February 12, 2025
概括
代谢失调,包括能源生产和营养物质加工问题,显著导致青光眼,这是导致失明的主要原因. 了解这些代谢变化为这种复杂的神经退行性疾病提供了新的治疗点.
科学领域:
- 眼科医生 眼科 眼科
- 神经科学是一个神经科学.
- 代谢研究研究 代谢研究
背景情况:
- 玻璃眼是全球不可逆转失明的主要原因,其特征是视网膜质细胞 (RGC) 损失.
- 代谢失调越来越被认为是青光眼发育和进展的关键因素.
研究的目的:
- 审查代谢过程和青光眼之间的复杂关系.
- 突出关键机制,包括RGCs中的线粒体,脂质和葡萄糖代谢.
- 探索特定代谢物及其调节失调在玻璃眼损伤中的作用.
主要方法:
- 文献综述,重点关注绿眼病中的代谢途径.
- 对RGC中的线粒体功能,脂质代谢和葡萄糖代谢研究的分析.
- 检查代谢变化,眼内压力和眼睛血流之间的相互作用.
主要成果:
- 线粒体功能障碍损害了能量生产,损害了RGC的生存能力.
- 改变的脂质代谢和过氧化有助于RGC损伤和亡.
- 葡萄糖代谢的干扰减少了对RGC生存至关重要的能量和神经营养支持.
- 乳酸酸和谷氨酸等失调的代谢物加剧了玻璃眼损伤.
结论:
- 代谢失调是绿眼病中RGC神经退行的一个关键驱动因素.
- 了解这些代谢途径为新的治疗策略提供了基础.
- 准代谢功能障碍可能为治疗青光瘤和改善患者结果提供新的途径.
相关概念视频
Glaucoma: Overview
496
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
496
Open Angle Glaucoma: Treatment
386
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
386
Angle Closure Glaucoma: Treatment
432
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
432
Glucose Transporters
22.4K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.4K
Photoreceptors and Visual Pathways
5.6K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
5.6K
Hypoglycemia and Glucagon
149
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
149


